News

Gastroenterology Advisor22h

Cardiovascular Benefit Seen With Tirzepatide in Head-to-Head Trial

SURPASS-CVOT evaluated the efficacy and safety of tirzepatide compared with dulaglutide in adults with T2D and a confirmed ASCVD.
NewsNation on MSN22h

Daily weight loss pill sees success in trials: Eli Lilly

Eli Lilly said it plans to submit the pill to the Food and Drug Administration for approval as a weight loss medication this year.